AVE 33.3% 0.2¢ avecho biotechnology limited

esra ogru background, page-27

  1. 1,053 Posts.
    lightbulb Created with Sketch. 4
    KC - you will be much closer to the mark than the Australian. Unless my judge of character is completely wrong Esra was never in this game for the money - it was all about the science and if she did take this money I am sure it wasn't for some real estate or shopping splurge. I guess we will find out eventually but ultimately if it really was all linked to one person and was fraudulent we can be sure we will be getting some cash back and that on top of our already better than expected cash position has to be a good thing.

    Paul Gavin is our chief scientist and before her untimely departure (playez you will be happy) Esra told me they had a publishing timetable set in place after they were happy their IP was fully protected for the final commercial product.

    I liked Esra a lot and am deeply saddened by this news both for the company AND for her personally - BUT the company is bigger than one person and there have been many on here saying it was time to turn this from a research company into a commercial deal making company.....Harry has more personal skin in this game than anyone and he sure knows how to close a deal.

    With trial results due in the coming weeks I personally see no rush in finding a CEO as if Harry is happy to commit to the role for the next year his reputation and back pocket could be well rewarded by keeping the team focused on landing Australia's largest licensing deal.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $17 5.798K

Buyers (Bids)

No. Vol. Price($)
55 95690716 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59980558 19
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.